APP and schizophrenia: Interestingly, among the 10 top options (lowest HR) in this regard nine were APP, seven of the APP included CLZ, and the only monotherapy was CLZ—attesting to APP usefulness, as well as to the distinctive position of CLZ in schizophrenia treatment.